Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jul 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$91K
Net Open-Market Flow
-$91K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2024Option exercise(M)1K$6.49$9K3K
Jul 1, 2024Sell(S)4K$21.36$91K2K
Jul 1, 2024Option exercise(M)3K$8.04$23K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2024Option exercise(M)1K—$012K
Jul 1, 2024Option exercise(M)3K—$034K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-081626) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML